# Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis

> **NCT03377465** · NA · COMPLETED · sponsor: **Medical University of Lodz** · enrollment: 100 (actual)

## Conditions studied

- Embolic Stroke of Undetermined Source
- Ischemic Stroke
- Atrial Fibrillation and Flutter
- Myocardial Infarction
- Cardiac Tumor
- Endocarditis
- Patent Foramen Ovale

## Interventions

- **DIAGNOSTIC_TEST:** ADMA (asymmetric dimethylarginine) , NTproBNP (N-terminal pro b-type natriuretic peptide), IL-6 (Interleukin 6), Adiponectina, Leptine, Syndecan, Resistin

## Key facts

- **NCT ID:** NCT03377465
- **Lead sponsor:** Medical University of Lodz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-15
- **Primary completion:** 2017-11-30
- **Final completion:** 2017-12-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03377465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03377465, "Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03377465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*